Cite
HARVARD Citation
Paul, S. et al. (n.d.). Soluble Mucosal Addressin Cell Adhesion Molecule 1 and Retinoic Acid are Potential Tools for Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease Treated with Vedolizumab: A Proof of Concept Study. Journal of Crohn's and colitis. pp. 1089-1096. [Online].